Skip to main content
. Author manuscript; available in PMC: 2014 Dec 28.
Published in final edited form as: J Control Release. 2013 Oct 2;172(3):1045–1064. doi: 10.1016/j.jconrel.2013.09.026

Fig. 4.

Fig. 4

Albumin-bound paclitaxel (Abraxane). Purple represents hydrophobic regions. Particle size 7 nm or 67 kDa (size of albumin protein). FDA approval 2005 for treating advanced metastatic breast cancer. Recommended dose is 260 mg/m every 3 weeks while tolerated [186].